Skip to main content

ROR-PH-301 ADVANCE OUTCOMES - A Study Evaluating the Efficacy and Safety of Ralinepag To Improve Treatment Outcomes in PAH Patients

NCT03683186

ADVANCE OUTCOMES - A Study Evaluating the Efficacy and Safety of Ralinepag To Improve Treatment Outcomes in PAH Patients

Principal Investigator

Sponsor

United Therapeutics

A research study is a scientific way to improve or develop new methods of health care. Studies are designed to answer specific questions on how to prevent, diagnose, or treat diseases and disorders. Many types of research studies exist. For example, the purpose of this research study is to assess an investigational medication called ralinepag (also referred to as the “investigational study drug”) in the treatment of pulmonary arterial hypertension (PAH). Ralinepag has not been approved by any regulatory authorities, including the US Food and Drug Administration (FDA); therefore, it is not available by prescription.

This study is currently enrolling.